Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 46, 2262-2265, May 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukhtar, H.
Right arrow Articles by Bickers, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukhtar, H.
Right arrow Articles by Bickers, D. R.

Inhibition of 3-Methylcholanthrene-induced Skin Tumorigenicity in BALB/c Mice by Chronic Oral Feeding of Trace Amounts of Ellagic Acid in Drinking Water1

Hasan Mukhtar2, Mukul Das3 and David R. Bickers

Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, and Veterans Administration Medical Center, Cleveland, Ohio, 44106

Chronic p.o. feeding of small amounts of ellagic acid, a naturally occurring dietary plant phenol, to BALB/c mice in drinking water afforded significant protection against skin tumorigenesis induced by 3-methylcholanthrene, a polycyclic aromatic hydrocarbon carcinogen. A significant increase in the latent period for the development of skin tumors by 3-methylcholanthrene was observed in the ellagic acid-fed group of mice (9 wk on test) as compared to the control group of animals (6 wk on test). The observed protection against tumor induction in the ellagic acid-fed group of animals may be due to the inhibition of the metabolic activation of the polycyclic aromatic hydrocarbon since epidermal aryl hydrocarbon hydroxylase activity was found to be significantly inhibited. Our results suggest that dietary supplementation with small amounts of ellagic acid may prove useful in reducing the risk of skin carcinogenesis induced by environmental chemicals.

1 Supported in part by NIH Grants CA 38028, ES 1900, and AM 34368 and funds from the Veterans Administration.

2 To whom requests for reprints should be addressed, at Veterans Administration Medical Center, 10701 East Boulevard, Cleveland, OH 44106.

3 Recipient of the Burroughs Wellcome Fund fellowship award from the Dermatology Foundation.

Received 4/ 1/85. Revised 8/23/85. Revised 11/21/85. Revised 1/22/86. Accepted 1/27/86.




This article has been cited by other articles:


Home page
J. Nutr.Home page
H. Carlsen, M. C. W. Myhrstad, M. Thoresen, J. O. Moskaug, and R. Blomhoff
Berry Intake Increases the Activity of the {gamma}-Glutamylcysteine Synthetase Promoter in Transgenic Reporter Mice
J. Nutr., July 1, 2003; 133(7): 2137 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
S Ahmed, A Rahman, M Saleem, M Athar, and S Sultana
Ellagic acid ameliorates nickel induced biochemical alterations: diminution of oxidative stress
Human and Experimental Toxicology, November 1, 1999; 18(11): 691 - 698.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1986 by the American Association for Cancer Research.